36
should wear a new pair of protective gloves before
testing each new patient.
4. Only auto-disabling, single-use lancing devices may
be used with this system.
5. For more information, refer to the following refer-
ences:
“Guideline for Isolation Precautions: Preventing Trans mission of Infectious Agents in
Healthcare Settings 2007,” http://www.cdc.gov/hicpac/2007ip/2007isolatio nprecau-
tons.html.
Biosafety in Microbiological and Biomedical Laboratories (BMBL) found at https://
www.cdc.gov/labs/BMBL.html.
“Protection of Laboratory Workers From Occupationally Acquired Infection ; Approved
Guideline - Fourth Edition ,” Clinical and Laboratory Standards Institute (CLSI) M29-
A4. http://www.fda.gov/Medicaldevices/Safety/ AlertsandNotices/ucm224025.html.
“CDC Clinical Reminder: Use of Fingerstick Devices.” https://www.cdc.gov/injection-
safety/ngerstick-devicesbgm.html.
Testing: Blood and Quality Control Solutions
PN62659B1 Lactate Plus IFU EN.indd 36PN62659B1 Lactate Plus IFU EN.indd 36 8/5/22 11:55 AM8/5/22 11:55 AM